News Dec 06, 2010
The article, written by Wei and Fabio Garofolo, details the challenges and opportunities faced by pharmaceutical companies and the current and future global outsourcing strategies.
The article is published online within the Future Science journal, Bioanalysis and is free to access.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE